Gene Therapy in Amyotrophic Lateral Sclerosis

Since the discovery of Cu/Zn superoxide dismutase (SOD1) gene mutation, in 1993, as the first genetic abnormality in amyotrophic lateral sclerosis (ALS), over 50 genes have been identified as either cause or modifier in ALS and ALS/frontotemporal dementia (FTD) spectrum disease. Mutations in C9orf72...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Ton, Je, Goun, Pacut, Peter, Keyhanian, Kiandokht, Gao, Jeff, Ghasemi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265980/
https://www.ncbi.nlm.nih.gov/pubmed/35805149
http://dx.doi.org/10.3390/cells11132066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265980/
https://www.ncbi.nlm.nih.gov/pubmed/35805149
http://dx.doi.org/10.3390/cells11132066

Ejemplares similares